Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HPN217 |
Synonyms | |
Therapy Description |
HPN217 is a tri-specific molecule that targets BCMA (TNFRSF17) and CD3 epsilon domain (CD3e), as well as human serum albumin, which potentially results in activation of T-cell response and increased death of BCMA-expressing tumor cells (Blood (2018) 132 (Supplement 1): 3225). |